LOS ANGELES, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, a company focused on gene-modified cellular therapy in infectious disease and cancer, announces the expansion of its infectious disease pipeline by entering into an agreement in principle to acquire an exclusive, license for a treatment under development aimed to treat the Hepatitis B Virus (HBV) infections from G-Tech Bio, LLC. An abstract accepted for presentation at the HepDART meeting featuring in vivo and in vitro data from preclinical studies conducted with this novel HBV treatment candidate will be presented by Dr. Serhat Gmrkc, MD, PhD on December 10, 2019. Approximately 5 percent of the worlds population is infected with HBV, and around 1 million people per year die from the disease.
The widely respected and well-published collaborating scientist, Dr. Philippe Gallay, PhD, of the Scripps Institute said, I have been working in the hepatitis field for three decades. The mechanism of action conceived of by the brilliant scientist, Dr. Gmrkc, is remarkably innovative. The data generated thus far have exceeded my expectations. I look forward to the presentation at HepDART, an important conference for the field, and to advancing the work with Dr. Gmrkc and Enochian Biosciences.
Building on a Broad and Deep Pipeline
Based on the determinations from independent valuation specialists as contained in our audited financial statements for our fiscal year ended June 30, 2019, our intangible assets related primarily to our HIV pipeline are approximately $154.8 million. The addition of a treatment that we believe could have the potential to cure HBV expands an already exciting pipeline for Enochian.
Enochian licenses are for intellectual property that include proprietary know-how and pending patent applications covering aspects of our pipeline therapeutics. Additionally, Enochian intends to protect the therapeutics that may be approved for marketing in the future with regulatory exclusivity that is available in many jurisdictions around the world. These exclusivity strategies, which are based on pending patent applications, patents, if issued, and regulatory exclusivity, are common among biotech companies as therapeutic candidates proceed through pre-clinical and clinical stages leading to commercialization.
HIV
The cure for HIV has been demonstrated to be more than a theoretical possibility. The so called Berlin and London patients have been cured by undergoing a bone marrow transplant for cancer with cells from another person who had a naturally occurring genetic mutation that makes cells resistant to HIV infection. Unfortunately, this procedure causes a death rate of approximately one-third and causes significant and in some cases, life-long side effects for those who survive. Therefore, it can only be done in people who require a transplant for a life-threatening disease such as lymphoma. Several researchers and companies have attempted to genetically modify the cells of HIV-infected persons and return (transplant) them back into the same person, hoping to reduce the significant side effects with the approach used in the Berlin and London patients. However, the chemotherapy used is still rather toxic, and more significantly, there has not been significant uptake (engraftment) of the genetically modified cells, so the patients have not been cured.
HV-01: a New Approach Toward a Potential Cure for HIV
HV-01 was the original impetus for the conception of Enochian Biosciences HIV focus. It is based on an insight by Dr. Gmrkc, drawn from a non-HIV field, that by adding an additional genetic modification to cells beyond those that protect cells from HIV infection could give a competitive advantage to the survival of the cells in HIV patients, leading to enhanced engraftment of the cells and increase the potential for a cure. This approach could also significantly reduce the therapies needed, potentially allowing the procedure to be done on an outpatient basis.
The results from in vitro and in vivo pre-clinical studies being conducted by Dr. Gallays laboratory and Scripps Institute and Enochians lab have thus far exceeded expectations. Therefore, an Initial Targeted Engagement for Regulatory Advice on CBER ProducTs (INTERACT) meeting package, which we expect will assist us in initiating the Investigational New Drug (IND) process with the FDA, is being prepared. We are seeking to potentially submit that package in December, meeting our original goal of submission before the end of 2019.
HV-11 and HV-12: A Potential Preventive and Therapeutic Vaccine for HIV
Novel approaches to stimulate a persons immune response to more effectively respond to HIV could be used to prevent infection (preventive vaccine) or to allow an HIV-infected person to control HIV infection in the absence of any other treatment (therapeutic vaccine).
Enochian has partnered with one of the leading scientists and scientific institutions, Dr. Hans Peter Kiem, MD PhD, of the Fred Hutchinson Cancer Research Center, to test an innovative approach in non-human primates that we believe has the potential for development into a preventive and/or therapeutic/curative vaccine. Dr. Kiem said, We are very excited to be involved with this study. Dr. Gmrkcs scientific insight for the work is truly unique. I know of no similar approach being evaluated anywhere else in the world.
HIV 31 and 32: Potential new class of HIV treatment
Based on the innovative mechanism of action designed to be developed into a potential cure for HBV, Dr. Gmrkcs two novel approaches aimed at an alternative path to cure and/or treat HIV are in the discovery phase.
Oncology
Building on learning from peer-reviewed publications of Phase I/IIa trials, we are designing an innovative dendritic-cell based therapeutic vaccination platform that could potentially be developed into treatments to induce life-long remissions from some of the deadliest solid tumors. We plan to initially target pancreatic cancer, triple negative breast cancer, glioblastoma, and renal cell carcinoma with this platform. The platform might also allow for non-specific immune enhancement that could have the potential for impact against a broad array of solid tumors. As with HIV, our approach could potentially allow for outpatient therapy without ablating or significantly impairing the patients immune system, as many current approaches require.
Experimental designs have been created to develop our approach, including the procurement of vectors. We expect that the platform could move beyond the discovery phase in the coming months.
Building the Capital Foundation to Advance the Pipeline
Enochian has recently entered into agreements that upon satisfaction of certain closing conditions and closing will provide an additional $12 million in funding. Based on current projections, we believe these resources should be sufficient to advance the pipeline through pre-clinical phases into Phase I trials if IND approvals are secured.
The Inventor
After receiving his preclinical training at the Dokuz Eylul University in 2004, Dr. Serhat Gmrkc continued his training in various institutions and started working as a physician licensed by the Ministry of Health of Turkey in 2008. Later, after working under Dr. Suat Arusan in Turkey, Dr. Gmrkc decided to explore further studies in the field of cell and gene therapies. He is currently the director of Seraph Research Institute, a non-profit organization where he runs a research lab at the cutting edge of cell, gene and immunotherapy research. On agreeing to join the Institutes scientific board, one of the worlds leading experts and his mentor in immuno-oncology, Prof. Shimon Slavin said, Dr. Gmrkc was a young Turkish post-doc with interesting ideas when I first met him eight years ago. I am looking forward to our future collaboration in developing and implementing novel cancer treatments at Seraph Research Institute.
His interest in other fields of science, such as physics, has led him to pursue creating cross-disciplinary solutions to complex human diseases as a researcher. Based on his unique research training, Dr. Gmrkc has become a prolific inventor, submitting various patent/provisional patent applications, which include several approaches aimed to treat or potentially cure HIV/AIDS, Hepatitis B, major solid tumors, rare but deadly diseases, and for a novel vaccine for HIV among many others.
Dr. Gmrkc has licensed intellectual property related to HIV and several solid tumors to Enochian. Dr. Mark Dybul, MD, said, Dr. Gmrkc is one of those rare geniuses that is not bound by scientific discipline or dogma. He sees connections and opportunities often missed. His ideas are the purest kind: those that seem so obvious and simple once he has conceived of, and explained them.
About the Company
Enochian Biosciences is a pre-clinical stage biotechnology company committed to using its exclusive licenses for genetically modified cellular and immune-therapy technologies to seek to prevent or potentially cure HIV, to potentially provide life-long cancer remission of some of the deadliest cancers and to potentially cure HBV. We intend to do this by genetically modifying, or re-engineering, different types of cells, depending on the therapeutic area and then injecting or reinfusing the re-engineered cells back into the patient to provide treatment.
Forward-Looking Statements
Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline or the sufficiency of our funding. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as believes, plans, expects, aims, intends or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Enochians most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Enochian undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.
Originally posted here:
Enochian Biosciences Expands its Infectious Disease Pipeline by Entering into an Agreement in Principle to Acquire an Exclusive License for a Novel...
- Main Show Only - Genetic Engineering - Coast to Coast AM - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- RTPB | Genetic Engineering [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Stop Monsanto From Poisoning Hawai'i: Genetic Engineering Chemical Warfare - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Informatics 161 PSA: Human Genetic Engineering - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Don't Trust Whole Foods or Other Health Food Stores For Non- GMO Foods | Genetic Engineering - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Genetic Engineering - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Easier Genetic Engineering! (Brainstorm Ep69) - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- TEDxUCIrvine - Francisco Ayala - Cloning, Genetic Engineering, [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Genetic Engineering in Agriculture - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Infowars Special Report : Genetic Engineering - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Glowing Rats and Extreme Genetic Engineering - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Endangered Cat Born at Audubon - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Danger of Genetic Engineering - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- AQA GCSE core science and B1 - Genetic Engineering - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- genetic engineering rDNA.wmv - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Genetic Engineering for Human Enhancement.mp4 - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Genetic Engineering - Seven Wonders of the Microbe World (6/7) - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Promising new drug target for inflammatory lung diseases [Last Updated On: September 8th, 2012] [Originally Added On: September 8th, 2012]
- Mandatory GM Labeling Would Require Major Change [Last Updated On: September 10th, 2012] [Originally Added On: September 10th, 2012]
- GEN reports on ocular therapeutics targeting the retina [Last Updated On: September 11th, 2012] [Originally Added On: September 11th, 2012]
- Prop. 37: Another example of the perils of the initiative process [Last Updated On: September 15th, 2012] [Originally Added On: September 15th, 2012]
- Genetic test predicts risk for Autism [Last Updated On: September 19th, 2012] [Originally Added On: September 19th, 2012]
- Immediate withdrawal of unsafe GE corn vital - Greens [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- Immediate withdrawal of unsafe GE corn vital [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- NZ out of step on GE [Last Updated On: September 21st, 2012] [Originally Added On: September 21st, 2012]
- Ballot Watch: Labeling genetically engineered foods [Last Updated On: September 30th, 2012] [Originally Added On: September 30th, 2012]
- Just another GE mirage [Last Updated On: October 2nd, 2012] [Originally Added On: October 2nd, 2012]
- The GM Barnyard [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- Free Engine [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- Cellectis Publishes Results Paving the Way for New Therapeutic Approaches against Cancer and Genetic Diseases [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- Does moral decision-making in video games mirror the real world? [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- Animals engineered with pinpoint accuracy [Last Updated On: October 3rd, 2012] [Originally Added On: October 3rd, 2012]
- Valley farmers fear 'modified' wording in Prop. 37 [Last Updated On: October 4th, 2012] [Originally Added On: October 4th, 2012]
- No on Proposition 37 [Last Updated On: October 4th, 2012] [Originally Added On: October 4th, 2012]
- The Dangers of Genetic Engineering [Last Updated On: October 5th, 2012] [Originally Added On: October 5th, 2012]
- Are inhaled medications effective and safe in critically ill patients on mechanical ventilation? [Last Updated On: October 5th, 2012] [Originally Added On: October 5th, 2012]
- Calif. initiative will test appetite for GMO food [Last Updated On: October 7th, 2012] [Originally Added On: October 7th, 2012]
- Calif. initiative will test appetite for GMO food - Sat, 06 Oct 2012 PST [Last Updated On: October 7th, 2012] [Originally Added On: October 7th, 2012]
- California to vote on 'genetically modified' labels [Last Updated On: October 7th, 2012] [Originally Added On: October 7th, 2012]
- California initiative will test appetite for genetically modified foods [Last Updated On: October 7th, 2012] [Originally Added On: October 7th, 2012]
- Do we have an appetite for genetically modified food? [Last Updated On: October 7th, 2012] [Originally Added On: October 7th, 2012]
- Genetic labelling mooted in California [Last Updated On: October 7th, 2012] [Originally Added On: October 7th, 2012]
- California initiative to test appetite for 'genetically engineered' food [Last Updated On: October 7th, 2012] [Originally Added On: October 7th, 2012]
- New tool for making genetic engineering of microbial circuits reliably predictable [Last Updated On: October 10th, 2012] [Originally Added On: October 10th, 2012]
- Researchers develop new tool for making genetic engineering of microbial circuits reliably predictable [Last Updated On: October 10th, 2012] [Originally Added On: October 10th, 2012]
- A Welcome Predictability [Last Updated On: October 10th, 2012] [Originally Added On: October 10th, 2012]
- Engineered flies spill secret of seizures [Last Updated On: October 12th, 2012] [Originally Added On: October 12th, 2012]
- Genetic 'remix' key to evolution of bee behavior, researchers find [Last Updated On: October 15th, 2012] [Originally Added On: October 15th, 2012]
- Can vaccines be delivered via the lungs instead of by injection? [Last Updated On: October 15th, 2012] [Originally Added On: October 15th, 2012]
- Food labeling regulations [Last Updated On: October 16th, 2012] [Originally Added On: October 16th, 2012]
- Research and Markets: Therapeutic Antibody Engineering: Current and Future Advances Driving the Strongest Growth Area ... [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Is there a difference between GE & GMO? [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Port Townsend Food Coop: A Sad Story of GMO Crop Cross Pollination - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- PUT IT IN YOUR MOUTH! Yes to Prop 37 — it's your right to know what's in your food! - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- editta braun company: planet LUVOS (clip, 4:30) - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Mimic: The Director's Cut (Blu-ray Trailer) - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- South Park Season 1 Episode 7 - An Elephant Makes Love to a Pig - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Yes on Prop 37: Animated Video - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- The Day of the Triffids Part 1 Full Movie - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- YES on prop 37 "flashmob" march - Santa Cruz, CA Sept. 2012 - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- World's Weirdest Places Discussed - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- THE CLUB OF ROME - DEPOPULATION AGENDA 21 - THE UNHIVED MIND - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- 27-Medical BiotechnologySG Part II.Gene Therapy, Tissue Engineering and Nanotechnology.mov - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- 26-Medical BiotechnologySG Part Ic. Animal and Human Cloning and Genetic Engineering.mov - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- How to Clone Animals - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Fringe Opening sequence (Season 3 - The Day We Died) - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Fringe Opening sequence (Season 3 - Olivia) - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Fringe Opening sequence (Season 3 - Entrada) - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Fringe Opening sequence (Season 4) - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Fringe Opening sequence (Season 3) - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Fringe Opening sequence (Season 2) - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Fringe Opening sequence (1985) - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Dendritic Cells: Biology And Clinical Applications - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Port Townsend Food Coop: "I want my food untainted by GMOs" - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Catholic Priest vs. Biologist - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Watch Real Life Superhero Muscles Like Marvel's The Avengers - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Fringe Opening sequence (Season 1) - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Fringe Opening sequence (The Final Season: "Fight For The Future") - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- Port Townsend Food Coop: I Want To Know If GMOs Are In My Food - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- ProCognia jumps on expanded biosimilar collaboration [Last Updated On: November 7th, 2012] [Originally Added On: November 7th, 2012]